James A. Schoeneck

2020 - FibroGen

In 2020, James A. Schoeneck earned a total compensation of $717.3K as Interim Chief Executive Officer at FibroGen, a 86% decrease compared to previous year.

Compensation breakdown

Salary$200,000
Other$517,343
Total$717,343

Schoeneck received $517.3K in other compensation, accounting for 72% of the total pay in 2020.

Schoeneck also received $200K in salary.

Rankings

In 2020, James A. Schoeneck's compensation ranked 9,895th out of 13,090 executives tracked by ExecPay. In other words, Schoeneck earned more than 24.4% of executives.

ClassificationRankingPercentile
All
9,895
out of 13,090
24th
Division
Manufacturing
4,251
out of 5,621
24th
Major group
Chemicals And Allied Products
1,747
out of 2,254
23rd
Industry group
Drugs
1,530
out of 1,954
22nd
Industry
Pharmaceutical Preparations
1,129
out of 1,459
23rd

Pay ratio

James A. Schoeneck's Pay$717,343
Median Employee's Pay$177,952
Pay Ratio

4

to 1

In 2020, the annual total compensation of James A. Schoeneck was $717,343.

The annual total compensation of the median employee at FibroGen was $177,952.

The ratio of James A. Schoeneck's pay to the pay of median employee was therefore 4 to one.

Source: SEC filing on April 13, 2021.

Schoeneck's colleagues

We found seven more compensation records of executives who worked with James A. Schoeneck at FibroGen in 2020.

2020

Enrique Conterno

FibroGen

Chief Executive Officer

2020

Thane Wettig

FibroGen

Chief Commercial Officer

2020

Mark Eisner

FibroGen

Chief Medical Officer

2020

K Yu

FibroGen

Chief Medical Officer

2020

Pat Cotroneo

FibroGen

Chief Financial Officer

2020

Elias Kouchakji

FibroGen

Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance

2020

Christine Chung

FibroGen

Senior Vice President, China Operations

News

You may also like